Theragenics Corporation Agrees to Acquire CP Medical
Under the terms of the agreement, at closing Theragenics(TM) will pay cash of approximately $19,150,000 and issue approximately 1,885,370 shares valued at approximately $6,250,000 as calculated over a 20-day period from March 28, 2005 through April 22, 2005 for a total purchase price of approximately $25,400,000. Theragenics(TM) will finance the cash portion of the purchase price from cash on hand. CP Medical has no significant debt on its books. The consummation of the transaction is subject to customary closing conditions.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.